Ph.D. Jay R. Luly - 12 Feb 2025 SCHEDULE 13D/A Report for Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (ENTA)

Filing Manager: Ph.D. Jay R. Luly
Reporting Manager: Jay R. Luly, Ph.D.
Security: Enanta Pharmaceuticals, Inc. Common Stock, par value $0.01 per share
Symbol: ENTA
Shares outstanding: 22,124,883 shares
Disclosed Ownership: 1,703,616 shares
Ownership: 7.7%
Form type: SCHEDULE 13D/A
Filing time: 14 Feb 2025, 17:05:29 UTC
Date of event: 12 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Jay R. Luly, Ph.D.	7.7%	1,703,616	1,703,616	0	/s/ Jay R. Luly, Ph.D.	Jay R. Luly, Ph.D.	0001571211